ATE75775T1 - Verfahren zur herstellung von biologisch aktivem plasminogenaktivator. - Google Patents

Verfahren zur herstellung von biologisch aktivem plasminogenaktivator.

Info

Publication number
ATE75775T1
ATE75775T1 AT87304995T AT87304995T ATE75775T1 AT E75775 T1 ATE75775 T1 AT E75775T1 AT 87304995 T AT87304995 T AT 87304995T AT 87304995 T AT87304995 T AT 87304995T AT E75775 T1 ATE75775 T1 AT E75775T1
Authority
AT
Austria
Prior art keywords
plasminogen activator
production
biologically active
medium
culture
Prior art date
Application number
AT87304995T
Other languages
English (en)
Inventor
William R Arathoon
Stuart E Builder
Anthony S Lubiniecki
Reis Robert D Van
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE75775T1 publication Critical patent/ATE75775T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87304995T 1986-06-06 1987-06-05 Verfahren zur herstellung von biologisch aktivem plasminogenaktivator. ATE75775T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87164286A 1986-06-06 1986-06-06
EP87304995A EP0248675B1 (de) 1986-06-06 1987-06-05 Verfahren zur Herstellung von biologisch aktivem Plasminogenaktivator

Publications (1)

Publication Number Publication Date
ATE75775T1 true ATE75775T1 (de) 1992-05-15

Family

ID=25357832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87304995T ATE75775T1 (de) 1986-06-06 1987-06-05 Verfahren zur herstellung von biologisch aktivem plasminogenaktivator.

Country Status (21)

Country Link
US (1) US5053334A (de)
EP (1) EP0248675B1 (de)
JP (1) JPS6332484A (de)
KR (1) KR930002888B1 (de)
AT (1) ATE75775T1 (de)
AU (1) AU601984B2 (de)
DD (1) DD257087A5 (de)
DE (2) DE3718939C2 (de)
DK (1) DK175366B1 (de)
ES (1) ES2032444T3 (de)
FI (1) FI91886C (de)
FR (1) FR2599625B1 (de)
GB (1) GB2191493B (de)
GR (1) GR3005245T3 (de)
HU (1) HU205171B (de)
IE (1) IE60485B1 (de)
IL (1) IL82746A (de)
NO (1) NO170595C (de)
NZ (1) NZ220547A (de)
PT (1) PT84991B (de)
ZA (1) ZA874054B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82746A (en) * 1986-06-06 1994-10-07 Genentech Inc Process for producing biologically active tissue-type plasminogen activator
JP2576200B2 (ja) * 1988-03-09 1997-01-29 味の素株式会社 生理活性タンパク質の製造法
EP0338716A3 (de) * 1988-04-21 1990-04-11 Berlex Laboratories, Inc. Methode und Vorrichtung zur Produktion nichtdegradierter Proteine aus Säugetierzellen
DE3829244A1 (de) * 1988-08-29 1990-03-01 Boehringer Mannheim Gmbh Verfahren zur herstellung von einkettigem t-pa
EP0391080A3 (de) * 1989-03-07 1990-11-07 Roche Diagnostics GmbH Verfahren zur Herstellung von zweikettigem t-PA
GB2249099B (en) * 1990-09-26 1995-05-03 Squibb & Sons Inc Squalene synthetase
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
US6077940A (en) * 1997-12-24 2000-06-20 Genentech, Inc. Free solution ligand interaction molecular separation method
US8492140B2 (en) 2002-04-08 2013-07-23 Octane Biotech Inc. Automated tissue engineering system
BRPI0714347A2 (pt) * 2006-07-14 2013-05-07 Dsm Ip Assets Bv processo aperfeiÇoado para o cultivo de cÉlulas
EP2188371B1 (de) * 2007-08-09 2017-12-20 Wyeth LLC Verwendung von perfusion zur erhöhung der produktion von fed-batch-zellkulturen in bioreaktoren
WO2011091248A1 (en) * 2010-01-22 2011-07-28 Lonza Walkersville, Inc. High yield method and apparatus for volume reduction and washing of therapeutic cells using tangential flow filtration
US10934519B2 (en) * 2011-07-29 2021-03-02 Global Life Sciences Solutions Usa Llc Systems, methods and control laws for cell harvesting
US9695393B2 (en) * 2012-08-20 2017-07-04 Terumo Bct, Inc. Concentrating components of fluid circulated through a cell growth chamber
US11447745B2 (en) 2017-09-01 2022-09-20 Lonza Walkersville, Inc. End-to-end cell therapy automation
WO2020061696A1 (en) 2018-09-28 2020-04-02 Octane Biotech Inc. Magnetic separation
US11714096B2 (en) 2018-12-21 2023-08-01 Octane Biotech Inc. Carousel for modular biologic production units
KR20210108406A (ko) 2018-12-21 2021-09-02 론자 워커스빌 아이엔씨. 바이러스 벡터의 자동화된 생산
EP3902906A4 (de) 2018-12-28 2022-11-09 Octane Biotech Inc. Zellkultur- und gewebezüchtungssysteme mit kontrollierten umweltzonen
US11773365B2 (en) 2019-02-08 2023-10-03 Lonza Walkersville, Inc. Cell concentration methods and devices for use in automated bioreactors
CN114729292A (zh) 2019-10-24 2022-07-08 奥克泰生物科技股份有限公司 具有经改进的细胞接触表面的细胞培养室
JP2023501443A (ja) 2019-11-11 2023-01-18 ロンザ ウォーカーズヴィル，インコーポレーテッド 自動化された細胞処理のための品質制御方法
KR20240070501A (ko) 2021-07-02 2024-05-21 컴반지오, 인크. 세포 피브로넥틴 조성물의 제조 및 사용 방법

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904480A (en) * 1972-10-24 1975-09-09 Lilly Co Eli Enhanced production of plasminogen activator
JPS5329985A (en) * 1976-08-27 1978-03-20 Kanegafuchi Chem Ind Co Ltd High concentration culturing of yeast
JPS5571496A (en) * 1978-11-24 1980-05-29 Asahi Chem Ind Co Ltd Preparation of living substance
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4232124A (en) * 1979-04-23 1980-11-04 Mann George F Method of producing plasminogen activator
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
JPS5642584A (en) * 1979-09-18 1981-04-20 Asahi Chem Ind Co Ltd Cell cultivation method
US4420398A (en) * 1981-08-13 1983-12-13 American National Red Cross Filteration method for cell produced antiviral substances
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
US4537860A (en) * 1982-12-08 1985-08-27 Monsanto Company Static cell culture maintenance system
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
AU572108B2 (en) * 1983-01-19 1988-05-05 Genentech Inc. Human tpa production using vectors coding for dhfr protein
JPS59121172U (ja) * 1983-02-04 1984-08-15 ミネソタ・マイニング・アンド・マニユフアクチユアリング・コンパニ− ケーブル電線被覆の剥離部分のカバー装置
US4546083A (en) * 1983-04-22 1985-10-08 Stolle Research & Development Corporation Method and device for cell culture growth
DE3479520D1 (en) * 1983-11-21 1989-09-28 Ciba Geigy Ag Synthesis of tissue plasminogen activator(tpa) by yeast
US4740461A (en) * 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
US4888115A (en) * 1983-12-29 1989-12-19 Cuno, Incorporated Cross-flow filtration
US4757005A (en) * 1984-04-19 1988-07-12 Miles Inc. Method and cell line for obtaining plasminogen activators
EP0215923B1 (de) * 1985-03-22 1990-12-27 Chiron Corporation EXPRESSION VON tPA IN SÄUGETIERZELLEN
AU593264B2 (en) * 1985-07-10 1990-02-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor
AU606582B2 (en) * 1985-09-06 1991-02-14 Codon Methods for the recovery of tissue plasminogen activator
JPH07110232B2 (ja) * 1985-10-14 1995-11-29 株式会社日立製作所 遺伝子組換え大腸菌の遺伝子生産物を採取する方法および装置
IL82746A (en) * 1986-06-06 1994-10-07 Genentech Inc Process for producing biologically active tissue-type plasminogen activator

Also Published As

Publication number Publication date
IL82746A (en) 1994-10-07
US5053334A (en) 1991-10-01
EP0248675B1 (de) 1992-05-06
AU7387287A (en) 1987-12-10
DK175366B1 (da) 2004-09-13
FI91886B (fi) 1994-05-13
JPH0574346B2 (de) 1993-10-18
NO170595C (no) 1992-11-04
DE3718939C2 (de) 1998-09-17
NO170595B (no) 1992-07-27
AU601984B2 (en) 1990-09-27
GB8713267D0 (en) 1987-07-08
NZ220547A (en) 1990-01-29
IL82746A0 (en) 1987-12-20
GR3005245T3 (de) 1993-05-24
NO872395L (no) 1987-12-07
KR930002888B1 (ko) 1993-04-12
PT84991B (pt) 1990-03-08
EP0248675A1 (de) 1987-12-09
HUT43875A (en) 1987-12-28
PT84991A (en) 1987-07-01
IE871504L (en) 1987-12-06
FI872526A0 (fi) 1987-06-05
FR2599625B1 (fr) 1992-03-13
DK288187A (da) 1987-12-07
FI91886C (fi) 1994-08-25
FR2599625A1 (fr) 1987-12-11
DE3718939A1 (de) 1987-12-17
HU205171B (en) 1992-03-30
DE3778758D1 (de) 1992-06-11
JPS6332484A (ja) 1988-02-12
ES2032444T3 (es) 1993-02-16
DD257087A5 (de) 1988-06-01
ZA874054B (en) 1989-02-22
GB2191493A (en) 1987-12-16
NO872395D0 (no) 1987-06-05
IE60485B1 (en) 1994-07-27
DK288187D0 (da) 1987-06-04
KR880000590A (ko) 1988-03-28
GB2191493B (en) 1991-02-27
FI872526L (fi) 1987-12-07

Similar Documents

Publication Publication Date Title
DE3778758D1 (de) Verfahren zur herstellung von biologisch aktivem plasminogenaktivator.
DE69740002D1 (de) Tierzellen und verfahren für die replikation von influenza viren
ATE209679T1 (de) Proteine mit faktor viii aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende zusammensetzungen
DE69020850D1 (de) Pflanzengewebekulturverfahren zur Transformation von Pflanzenzellen.
ATE69266T1 (de) Verfahren zum herstellung von insulin-vorlaeufern und verfahren zur herstellung von humaninsulin.
ATE153214T1 (de) Medien zur zellzucht und verfahren dazu
ATE92530T1 (de) Transformation und expression eines fremden gens in -i(brassica) spezies.
ATE46358T1 (de) Verfahren zur zuechtung von lyophilisierten mikroorganismen.
DE3687699D1 (de) Verfahren und vorrichtung zum kultivieren von zellen.
FI871829A7 (fi) Nestemäisen soluviljelyväliaineen kalvosuodatusmenetelmä, jossa käytetään varattuja partikkeleita
ATE44428T1 (de) Verfahren zur befoerderung der regeneration von pflanzen aus gewebekulturen.
ATE72756T1 (de) Verfahren zur herstellung eines biologischen stoffes.
ATE132875T1 (de) Verfahren zur herstellung von zellprotein mit anti-hiv-wirkung
ATE13910T1 (de) Verfahren zur zuechtung von humanen fibroblasten und fibroblastenartigen zellen.
DE3485610D1 (de) Verfahren zur erhaltung und vermehrung von defekten, nicht-infektioesen virusgenomen.
DE3486168D1 (de) Verfahren zur herstellung von l-glutaminsaeure durch fermentation und dabei zu verwendende mutante mikroorganismen.
ATE2339T1 (de) Verfahren zur herstellung von sphingomyelinase, sphingomyelinase und deren verwendung.
SU1692145A1 (ru) Способ получения клеточной культуры
ATE5149T1 (de) Verfahren zur oberflaechenzuechtung kernhaltiger zellen und gewinnung von zellkultur-abhaengigen stoffen.
DE59004397D1 (de) Verfahren zur Kultivierung von Zellen in Mikrohohlkugeln.
JPS5794292A (en) Culturing of lymphoidoblast cell
ZA869449B (en) Growth-promoting cell culture medium and process for the cultivation of cells employing the same
ATE3725T1 (de) Verfahren zur mikroorganismenzucht.
ATE29042T1 (de) Verfahren zum einbringen von dna in eukaryotischen zellen zur herstellung von proteinen.
PL285546A1 (en) Biological culture medium for cell cultures and method of culturing human keratocytes as well as proteinous concentrate

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time